Top View
- Pathway Analysis of Commonly Expressed Genes Found in Primates and in Mouse During Naïve State of Pluripotenc Keggid Kegg Names
- The Role of the Rho GEF Arhgef2 in RAS Tumorigenesis
- The Small G-Proteins K-Ras, H-Ras, and N-Ras Function As GDP–GTP
- Structural Basis of Recognition of Farnesylated and Methylated Kras4b by Pdeδ
- Differential Activity of the KRAS Oncogene by Method of Activation: Implications for Signaling and Therapeutic Intervention
- Clinical Significance of HRAS and KRAS Genes Expression in Patients
- Developing Small Molecules That Inhibit K-Ras/GTP Binding Based on New
- Rheb Activates AMPK and Reduces P27kip1 Levels in Tsc2-Null Cells Via Mtorc1-Independent Mechanisms: Implications for Cell Proliferation and Tumorigenesis
- Understand KRAS and the Quest for Anti-Cancer Drugs
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- The Role of Wild-Type RAS in Oncogenic RAS Transformation
- An Oncogenic Mutant of RHEB, RHEB Y35N, Exhibits an Altered Interaction with BRAF Resulting in Cancer Transformation Jeffrey J
- Orexins/Hypocretins and Cancer: a Neuropeptide As Emerging Target
- KRAS Is a Novel Target for Melanoma and Contributes to Primary And
- GNAS Drives Pancreatic Tumourigenesis by Inducing PKA-Mediated SIK Suppression and Reprogramming Lipid Metabolism
- KRAS Interaction with RAF1 RAS-Binding Domain and Cysteine-Rich Domain Provides Insights Into RAS-Mediated RAF Activation
- Exploiting RAS Nucleotide Cycling As a Strategy for Drugging RAS-Driven Cancers
- GPCR Signaling As a Paradigm
- Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic
- KRAS Gene KRAS Proto-Oncogene, Gtpase
- Pathway Analysis of Commonly Expressed Genes Found in Humans and in Non-Human Primates During Naïve State O Keggid Kegg Namesig
- Molecular Assemblies of the Catalytic Domain of SOS with Kras and Oncogenic Mutants
- Regulation of Ras and Rho Gtpases by Post-Translational Modification: Cysteine Oxidation and Ubiquitination
- KRAS G13D Sensitivity to Neurofibromin-Mediated GTP Hydrolysis
- T Cells As a Drug for the Personalized Immunotherapy of Cancer
- Mutant Cancer with a Mutation‐Specific Inhibitor
- KRAS Teachers' Notes
- Early and Late Induction of KRAS and HRAS Proto-Oncogenes by Reactive Oxygen Species in Primary Astrocytes
- Variable G Protein Determinants of GPCR Coupling Selectivity
- Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
- Negative Mantle Cell Lymphoma
- An Oncogenic Mutant of RHEB, RHEB Y35N, Exhibits an Altered Interaction with BRAF Resulting in Cancer Transformation
- KRAS Vaccine (Mrna-5671) Last Program Update: August 5, 2021
- Structure and Regulation of Human Epithelial Cell Transforming 2 Protein
- Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
- Destabilization of Ran C-Terminus Promotes GTP Loading
- Structural Impact of GTP Binding on Downstream KRAS Signaling† Cite This: Chem
- Acute Amygdalar Activation Induces an Upregulation of Multiple
- Role of PTPRT in Obesity and Its Substrate Paxillin Tyrosine-88 in Colorectal Cancer
- BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers Through Combined MEK Inhibition
- Oncology Gene List
- 1 Supplemental Data Supplemental Figures
- Translating Biased Signaling in the Ghrelin Receptor System Into Differential in Vivo Functions
- HHS Public Access Author Manuscript
- Cancer Genetics of Sporadic Colorectal Cancer: BRAF and PI3KCA Mutations, Their Impact on Signaling and Novel Targeted Therapies
- Non-Coding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies
- KRAS and BRAF Mutations in Circulating Tumour DNA from Locally Advanced Rectal Cancer Received: 6 June 2017 Francesco Sclafani1, Ian Chau 1, David Cunningham1, Jens C
- RAS Symposium Program 2021
- The KRAS-G12C Inhibitor: Activity and Resistance
- Mechanisms of Carcinogenesis3 Molecular Hallmarks of Cancer
- The Ins and Outs of RAS Effector Complexes
- Unusual KRAS Missense Mutation (P.E63K) in Patient with Juvenile Pilocytic Astrocytoma of the Tectum Lianne Q Chau,1 Michael L Levy,2 John Ross Crawford3
- UNIVERSITY of CALIFORNIA Los Angeles Characterization of Rheb
- Uncovering a Membrane-Distal Conformation of KRAS Available to Recruit RAF to the Plasma Membrane
- Abstract Gap Engineering to Restore Gtp Hydrolysis To
- Kras (Kirsten Rat Sarcoma)
- Amplification of Mutant KRASG12D in a Patient with Advanced Metastatic Pancreatic Adenocarcinoma Detected by Liquid Biopsy: a Case Report
- Structures of N-Terminally Processed KRAS Provide Insight Into the Role of N-Acetylation Received: 16 October 2018 Srisathiyanarayanan Dharmaiah1, Timothy H
- Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities
- Recent Updates on the Significance of KRAS Mutations in Colorectal
- The Small Gtpases Ras and Rheb Studied by Multidimensional NMR Spectroscopy: Structure and Function